Grenville Strategic Royalty Corp.

Overview

Grenville Strategic Royalty Corp. is a Toronto-based private investment firm specializing in royalty-based financing for established businesses with revenues up to $50 million. The firm offers non-dilutive capital solutions, generating revenue through royalty payments, buyouts, and equity returns. This approach competes directly with traditional equity financing, providing companies with long-term capital on more favorable commercial terms. Grenville's investment strategy focuses on growth-oriented companies across various sectors, including technology, healthcare, financial services, retail services, construction, and materials. The firm targets businesses in the growth and late stages, primarily in Canada and the United States. Investments typically range from $150,000 to $5 million, aligning with the firm's commitment to supporting established companies seeking flexible financing options. Over the years, Grenville has engaged in several notable transactions, such as a $1 million royalty agreement with Stability Healthcare Inc. in 2018, aimed at fueling the company's expansion. Additionally, the firm has been involved in restructuring investments, including a transaction with Lattice Biologics Ltd. in 2017, where Grenville acquired common shares in exchange for extinguishing a portion of its original royalty investment. These activities underscore Grenville's proactive approach to managing and optimizing its investment portfolio, ensuring alignment with the evolving needs of its investee companies.

Investment Focus

• Established businesses with revenues up to $50 million
• Growth-oriented companies seeking non-dilutive financing
• Businesses in growth and late stages in Canada and the United States

Portfolio Companies